• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MGN:GR

8.893 EUR 0.090 1.02%

As of 07:17:18 ET on 07/31/2014.

Snapshot for Mologen AG (MGN)

Open: 8.820 Day's Range: 8.657 - 9.084 Volume: 14,447
Previous Close: 8.803 52wk Range: 8.250 - 13.610 1-Yr Rtn: -32.73%

Stock Chart for MGN

No chart data available.
  • MGN:GR 8.893
  • 1D
  • 1M
  • 1Y
8.803
Interactive MGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.8100
Est. EPS (EUR) (12/2014) -0.8820
Est. PEG Ratio -
Market Cap (M EUR) 148.75
Shares Outstanding (M) 16.96
30 Day Average Volume 20,823
Price/Book (mrq) 5.8266
Price/Sale (ttm) 663.3213
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MGN

Mologen AG researches, develops and markets products in the area of biotechnology and molecular medicine. The Company develops delivery technologies for DNA-based vaccines (gene therapy). In addition, Mologen writes software applications that are used in the laboratory by medical researchers.

Matthias SchroffChairman-Mgmt Board/CEOJoerg PetrassCFO/Member-Mgmt Board
Alfredo ZurloChief Medical Officer
More Company Profile & Key Executives for MGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil